marketcaparena
Search

    BCPC

    BALCHEM CORP

    Company overview

    Market capitalization
    $5.38B
    Employees
    1,368
    Latest publication
    2026-09-29
    About BALCHEM CORP

    Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue283,997,000USD270,709,000USD263,617,000USD267,558,000USD255,467,000USD250,519,000USD240,004,000USD239,940,000USD
    Cost Of Revenue180,314,000USD169,625,000USD169,718,000USD172,105,000USD162,354,000USD162,351,000USD153,667,000USD154,579,000USD
    Gross Profit103,683,000USD101,084,000USD93,899,000USD95,453,000USD93,113,000USD88,168,000USD86,337,000USD85,361,000USD
    Research Development4,534,000USD5,881,000USD5,052,000USD9,324,000USD4,662,000USD4,662,000USD4,510,000USD4,329,000USD
    Selling General Administrative18,791,000USD18,481,000USD1,129,000USD33,147,000USD18,071,000USD15,076,000USD16,668,000USD17,483,000USD
    General And Administrative Expenses18,791,000USD———————
    Total Operating Expenses44,462,000USD45,458,000USD33,830,000USD40,874,000USD41,671,000USD37,153,000USD38,893,000USD37,369,000USD
    Operating Income59,221,000USD55,626,000USD60,069,000USD54,579,000USD51,442,000USD51,015,000USD47,444,000USD47,992,000USD
    Total Other Income Expense Net-1,440,000USD-3,104,000USD-10,034,000USD-2,535,000USD-2,431,000USD-3,075,000USD-2,960,000USD-4,099,000USD
    Income Before Tax57,781,000USD52,522,000USD50,035,000USD52,044,000USD49,011,000USD47,940,000USD44,484,000USD43,893,000USD
    Income Tax Expense13,166,000USD12,237,000USD10,810,000USD11,755,000USD10,733,000USD10,887,000USD10,901,000USD10,056,000USD
    Net Income44,615,000USD40,285,000USD39,225,000USD40,289,000USD38,278,000USD37,053,000USD33,583,000USD33,837,000USD
    Selling And Marketing Expenses—21,096,000USD2,922,000USD—19,300,000USD16,926,000USD17,118,000USD15,557,000USD
    Interest Expense—3,104,000USD2,178,000USD2,351,000USD2,766,000USD2,924,000USD2,819,000USD4,071,000USD
    Net Interest Income—-2,213,000USD-1,900,000USD-2,629,000USD-2,766,000USD-2,924,000USD-2,819,000USD-4,071,000USD
    Tax Provision—12,237,000USD10,810,000USD11,755,000USD10,733,000USD10,887,000USD10,901,000USD10,056,000USD
    Net Income From Continuing Ops—40,285,000USD39,225,000USD40,289,000USD38,278,000USD37,053,000USD33,583,000USD33,837,000USD
    Ebit—54,735,000USD52,213,000USD54,395,000USD51,777,000USD50,864,000USD47,303,000USD47,964,000USD
    Ebitda—67,226,000USD63,436,000USD76,812,000USD63,180,000USD61,878,000USD58,199,000USD58,867,000USD
    Depreciation And Amortization—12,491,000USD11,223,000USD22,417,000USD11,403,000USD11,014,000USD10,896,000USD10,903,000USD
    Reconciled Depreciation—12,491,000USD11,721,000USD11,552,000USD11,403,000USD11,014,000USD10,896,000USD10,903,000USD
    Unclassified Operating Expenses——24,727,000USD-1,597,000USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue1,037,161,000USD953,684,000USD922,439,000USD942,358,000USD799,023,000USD703,644,000USD643,705,000USD643,679,000USD
    Cost Of Revenue666,528,000USD617,478,000USD620,383,000USD661,907,000USD555,849,000USD479,747,000USD432,338,000USD439,427,000USD
    Gross Profit370,633,000USD336,206,000USD302,056,000USD280,451,000USD243,174,000USD223,897,000USD211,367,000USD204,252,000USD
    Research Development18,510,000USD16,793,000USD15,049,000USD12,191,000USD13,524,000USD10,332,000USD11,377,000USD11,592,000USD
    Selling General Administrative67,423,000USD67,588,000USD55,734,000USD55,665,000USD41,735,000USD43,788,000USD36,505,000USD27,690,000USD
    Unclassified Operating Expenses66,368,000USD—72,080,000USD—————
    Total Operating Expenses152,301,000USD153,297,000USD142,863,000USD135,265,000USD115,672,000USD112,750,000USD108,814,000USD96,501,000USD
    Operating Income218,332,000USD182,909,000USD159,193,000USD145,186,000USD127,502,000USD111,147,000USD102,553,000USD107,100,000USD
    Interest Expense10,219,000USD16,528,000USD22,613,000USD10,268,000USD2,456,000USD4,439,000USD5,959,000USD7,611,000USD
    Net Interest Income-10,219,000USD-16,528,000USD-22,613,000USD-10,268,000USD-2,456,000USD-4,439,000USD-5,959,000USD-7,611,000USD
    Income Before Tax199,030,000USD166,453,000USD137,261,000USD133,749,000USD125,233,000USD106,417,000USD96,478,000USD99,030,000USD
    Income Tax Expense44,185,000USD37,978,000USD28,718,000USD28,382,000USD29,129,000USD21,794,000USD16,807,000USD20,457,000USD
    Tax Provision44,185,000USD37,978,000USD28,718,000USD28,382,000USD29,129,000USD21,794,000USD16,807,000USD20,457,000USD
    Net Income154,845,000USD128,475,000USD108,543,000USD105,367,000USD96,104,000USD84,623,000USD79,671,000USD78,573,000USD
    Net Income From Continuing Ops154,845,000USD128,475,000USD108,543,000USD105,367,000USD96,104,000USD84,623,000USD79,671,000USD78,573,000USD
    Ebit209,249,000USD182,981,000USD159,874,000USD144,017,000USD127,689,000USD110,856,000USD102,437,000USD106,641,000USD
    Ebitda254,441,000USD230,954,000USD214,809,000USD195,865,000USD176,568,000USD162,137,000USD148,299,000USD151,307,000USD
    Depreciation And Amortization45,192,000USD47,973,000USD54,935,000USD51,848,000USD48,879,000USD51,281,000USD45,862,000USD44,666,000USD
    Reconciled Depreciation45,690,000USD47,973,000USD54,935,000USD51,848,000USD48,879,000USD51,281,000USD45,862,000USD44,666,000USD
    Total Other Income Expense Net-19,302,000USD-16,456,000USD-21,932,000USD-11,437,000USD-2,269,000USD-4,730,000USD-6,075,000USD-8,070,000USD
    Selling And Marketing Expenses—68,916,000USD—67,409,000USD60,413,000USD58,630,000USD60,932,000USD57,219,000USD
    Non Operating Income Net Other———-1,169,000USD187,000USD-291,000USD-116,000USD-1,110,000USD
    Net Income Applicable To Common Shares———105,367,000USD96,104,000USD84,623,000USD79,671,000USD78,573,000USD
    Interest Income——————5,571,000USD7,405,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,687,004,000USD1,693,742,000USD1,707,559,000USD1,661,031,000USD1,678,247,000USD1,617,555,000USD1,575,371,000USD1,596,944,000USD
    Cash And Equivalents63,174,000USD———————
    Total Current Assets388,424,000USD388,941,000USD365,614,000USD343,715,000USD364,855,000USD340,239,000USD313,770,000USD325,988,000USD
    Other Current Assets5,331,000USD15,093,000USD15,999,000USD14,645,000USD15,296,000USD14,965,000USD13,791,000USD13,247,000USD
    Other Non Current Assets19,306,000USD———————
    Total Liabilities384,626,000USD———————
    Total Current Liabilities145,755,000USD152,540,000USD176,384,000USD126,369,000USD138,137,000USD139,555,000USD157,685,000USD109,439,000USD
    Other Current Liabilities51,791,000USD———————
    Total Stockholder Equity1,302,378,000USD1,285,116,000USD1,257,413,000USD1,297,864,000USD1,267,913,000USD1,208,701,000USD1,149,913,000USD1,177,226,000USD
    Total Equity Including Noncontrolling Interest1,302,378,000USD———————
    Net Receivables148,973,000USD154,232,000USD143,596,000USD131,542,000USD135,982,000USD130,447,000USD119,662,000USD120,537,000USD
    Inventory161,551,000USD146,743,000USD131,449,000USD132,435,000USD148,150,000USD144,926,000USD130,802,000USD118,510,000USD
    Property Plant Equipment Net317,405,000USD318,200,000USD322,840,000USD315,331,000USD307,369,000USD301,029,000USD299,204,000USD294,759,000USD
    Goodwill808,809,000USD———————
    Intangible Assets27,915,000USD156,462,000USD163,289,000USD167,459,000USD171,865,000USD165,965,000USD165,050,000USD177,525,000USD
    Accounts Payable70,451,000USD70,729,000USD60,425,000USD46,979,000USD67,864,000USD65,975,000USD54,745,000USD46,461,000USD
    Short Term Debt3,172,000USD3,651,000USD3,819,000USD4,145,000USD3,871,000USD3,923,000USD3,328,000USD3,403,000USD
    Common Stock2,132,000USD2,143,000USD2,139,000USD2,160,000USD2,165,000USD2,175,000USD2,170,000USD2,169,000USD
    Retained Earnings1,206,296,000USD1,161,681,000USD1,121,396,000USD1,113,113,000USD1,072,824,000USD1,034,546,000USD997,493,000USD992,380,000USD
    Accumulated Other Comprehensive Income27,209,000USD31,749,000USD41,547,000USD41,596,000USD41,512,000USD-2,263,000USD-23,747,000USD14,503,000USD
    Total Liab—408,626,000USD450,146,000USD363,167,000USD410,334,000USD408,854,000USD425,458,000USD419,718,000USD
    Other Current Liab—78,160,000USD112,140,000USD75,245,000USD66,402,000USD55,929,000USD95,146,000USD57,620,000USD
    Capital Stock—2,143,000USD2,139,000USD2,160,000USD2,165,000USD2,175,000USD2,170,000USD2,169,000USD
    Good Will—811,452,000USD816,375,000USD816,494,000USD816,391,000USD793,087,000USD780,030,000USD781,109,000USD
    Cash—72,873,000USD74,570,000USD65,093,000USD65,427,000USD49,901,000USD49,515,000USD73,694,000USD
    Cash And Short Term Investments—72,873,000USD74,570,000USD65,093,000USD65,427,000USD49,901,000USD49,515,000USD73,694,000USD
    Net Debt—111,841,000USD117,441,000USD106,905,000USD142,250,000USD158,165,000USD158,529,000USD171,596,000USD
    Short Long Term Debt Total—184,714,000USD192,011,000USD171,998,000USD207,677,000USD208,066,000USD208,044,000USD245,290,000USD
    Long Term Debt—169,000,000USD164,000,000USD154,000,000USD190,000,000USD190,000,000USD190,000,000USD227,000,000USD
    Property Plant Equipment Gross—581,983,000USD580,566,000USD566,774,000USD551,800,000USD537,762,000USD528,203,000USD520,016,000USD
    Common Stock Shares Outstanding—32,284,000shares32,320,000shares32,702,000shares32,744,000shares32,807,000shares32,548,000shares32,783,000shares
    Non Current Assets Total—1,304,801,000USD1,341,945,000USD1,317,316,000USD1,313,392,000USD1,277,316,000USD1,261,601,000USD1,270,956,000USD
    Non Current Liabilities Total—256,086,000USD273,762,000USD236,798,000USD272,197,000USD269,299,000USD267,773,000USD310,279,000USD
    Non Current Liabilities Other—21,647,000USD21,444,000USD21,343,000USD20,618,000USD19,939,000USD19,335,000USD17,932,000USD
    Non Currrent Assets Other—15,052,000USD14,417,000USD14,400,000USD14,051,000USD13,471,000USD13,461,000USD13,741,000USD
    Net Working Capital—236,401,000USD189,230,000USD217,346,000USD226,718,000USD200,684,000USD156,085,000USD216,549,000USD
    Unclassified Non Current Liabilities—65,439,000USD88,318,000USD61,455,000USD61,579,000USD59,360,000USD58,438,000USD65,347,000USD
    Unclassified Equity—87,400,000USD90,192,000USD138,835,000USD149,247,000USD172,068,000USD171,827,000USD166,005,000USD
    Unclassified Non Current Assets——25,024,000USD—————
    Unclassified Current Liabilities—————13,728,000USD4,466,000USD1,955,000USD
    Current Deferred Revenue——————-43,750,000USD-46,461,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,707,559,000USD1,575,371,000USD1,597,211,000USD1,624,512,000USD1,199,325,000USD1,165,843,000USD1,155,682,000USD981,355,000USD
    Intangible Assets163,289,000USD165,050,000USD191,212,000USD213,295,000USD94,665,000USD121,660,000USD143,924,000USD105,985,000USD
    Other Current Assets15,999,000USD13,791,000USD14,990,000USD17,997,000USD10,527,000USD13,483,000USD11,937,000USD5,314,000USD
    Total Liab450,146,000USD425,458,000USD543,227,000USD686,228,000USD322,310,000USD337,610,000USD412,015,000USD289,737,000USD
    Total Stockholder Equity1,257,413,000USD1,149,913,000USD1,053,984,000USD938,284,000USD877,015,000USD828,233,000USD743,667,000USD691,618,000USD
    Other Current Liab108,228,000USD95,146,000USD83,800,000USD76,418,000USD85,198,000USD68,349,000USD52,516,000USD48,267,000USD
    Common Stock2,139,000USD2,170,000USD2,152,000USD2,145,000USD2,154,000USD2,164,000USD2,161,000USD2,151,000USD
    Capital Stock2,139,000USD2,170,000USD2,152,000USD2,145,000USD2,154,000USD2,164,000USD2,161,000USD2,151,000USD
    Retained Earnings1,121,396,000USD997,493,000USD897,488,000USD814,487,000USD732,138,000USD656,740,000USD590,921,000USD528,027,000USD
    Good Will816,375,000USD780,030,000USD778,907,000USD769,509,000USD523,949,000USD529,463,000USD523,998,000USD447,995,000USD
    Cash74,570,000USD49,515,000USD64,447,000USD66,560,000USD103,239,000USD84,571,000USD65,672,000USD54,268,000USD
    Cash And Short Term Investments74,570,000USD49,515,000USD64,447,000USD66,560,000USD103,239,000USD84,571,000USD65,672,000USD54,268,000USD
    Total Current Assets365,614,000USD313,770,000USD314,242,000USD335,803,000USD322,232,000USD266,888,000USD254,946,000USD226,314,000USD
    Total Current Liabilities176,384,000USD157,685,000USD148,491,000USD140,042,000USD143,802,000USD94,428,000USD92,258,000USD82,056,000USD
    Net Debt117,441,000USD158,529,000USD265,887,000USD394,050,000USD5,330,000USD78,998,000USD182,897,000USD101,732,000USD
    Short Term Debt3,819,000USD3,328,000USD4,221,000USD4,022,000USD2,361,000USD2,337,000USD2,475,000USD—
    Short Long Term Debt Total192,011,000USD208,044,000USD330,334,000USD460,610,000USD124,642,000USD176,423,000USD258,871,000USD156,000,000USD
    Long Term Debt164,000,000USD190,000,000USD309,569,000USD440,569,000USD108,569,000USD174,086,000USD256,396,000USD163,372,000USD
    Net Receivables143,596,000USD119,662,000USD125,284,000USD131,578,000USD117,408,000USD98,214,000USD93,444,000USD99,545,000USD
    Inventory131,449,000USD130,802,000USD109,521,000USD119,668,000USD91,058,000USD70,620,000USD83,893,000USD67,187,000USD
    Accounts Payable60,425,000USD54,745,000USD55,503,000USD57,322,000USD56,243,000USD23,742,000USD37,267,000USD33,789,000USD
    Property Plant Equipment Net322,840,000USD299,204,000USD295,903,000USD290,787,000USD246,805,000USD236,506,000USD224,197,000USD194,339,000USD
    Property Plant Equipment Gross580,566,000USD528,203,000USD508,699,000USD290,787,000USD246,805,000USD236,506,000USD224,197,000USD194,339,000USD
    Accumulated Other Comprehensive Income41,547,000USD-23,747,000USD8,691,000USD-7,154,000USD-4,993,000USD4,173,000USD-5,564,000USD-3,602,000USD
    Common Stock Shares Outstanding32,604,000shares32,718,000shares32,448,000shares32,393,000shares32,671,999shares32,503,000shares32,505,000shares32,445,000shares
    Non Current Assets Total1,341,945,000USD1,261,601,000USD1,282,969,000USD1,288,709,000USD877,093,000USD898,955,000USD900,736,000USD755,041,000USD
    Non Current Liabilities Total273,762,000USD267,773,000USD394,736,000USD546,186,000USD178,508,000USD243,182,000USD319,757,000USD207,681,000USD
    Non Current Liabilities Other21,444,000USD19,335,000USD16,577,000USD26,814,000USD20,826,000USD6,079,000USD4,827,000USD7,372,000USD
    Non Currrent Assets Other14,417,000USD13,461,000USD12,871,000USD-51,961,000USD11,674,000USD11,326,000USD8,617,000USD-42,489,000USD
    Net Working Capital189,230,000USD156,085,000USD165,751,000USD195,761,000USD178,430,000USD172,460,000USD162,688,000USD144,258,000USD
    Unclassified Non Current Assets25,024,000USD———-11,674,000USD-19,736,000USD——
    Unclassified Current Liabilities3,912,000USD4,466,000USD-25,717,000USD2,280,000USD————
    Unclassified Non Current Liabilities88,318,000USD58,438,000USD68,590,000USD-73,579,000USD-67,281,000USD-56,297,000USD-64,590,000USD-59,053,000USD
    Unclassified Equity90,192,000USD171,827,000USD143,501,000USD126,661,000USD145,562,000USD170,865,000USD172,057,000USD162,947,000USD
    Current Deferred Revenue—-3,328,000USD30,684,000USD—————
    Deferred Long Term Liab———62,784,000USD46,455,000USD51,359,000USD58,534,000USD44,309,000USD
    Other Liab———89,598,000USD69,939,000USD67,955,000USD64,590,000USD51,681,000USD
    Other Assets———10,823,000USD11,674,000USD19,736,000USD4,104,000USD1,820,000USD
    Short Term Investments———1,406,000USD————
    Net Tangible Assets———168,775,000USD258,401,000USD298,770,000USD75,745,000USD137,638,000USD
    Treasury Stock—————-7,873,000USD-18,069,000USD-56,000USD
    Long Term Investments——————4,513,000USD4,902,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation24,711,000USD
    Stock Based Compensation11,277,000USD
    Deferred Income Tax-354,000USD
    Change To Account Receivables-6,452,000USD
    Change To Inventory-31,434,000USD
    Change To Liabilities4,823,000USD
    Change In Working Capital-35,960,000USD
    Operating Cash Flow86,772,000USD
    Other Investing Activities0USD
    Unclassified Investing Cash Flow-17,226,000USD
    Investing Cash Flow-17,226,000USD
    Net Debt Issuance-102,000USD
    Net Common Stock Issuance-44,484,000USD
    Common Dividends Paid-30,772,000USD
    Unclassified Financing Cash Flow-4,258,000USD
    Financing Cash Flow-79,616,000USD
    Effect Of Forex Changes On Cash-1,326,000USD
    Change In Cash-11,396,000USD
    End Cash Flow63,174,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income40,285,000USD39,225,000USD40,289,000USD38,278,000USD37,053,000USD33,583,000USD33,837,000USD32,069,000USD
    Depreciation12,491,000USD11,721,000USD11,552,000USD11,403,000USD11,014,000USD10,896,000USD10,903,000USD12,506,000USD
    Stock Based Compensation5,356,000USD3,759,000USD4,650,000USD5,838,000USD3,810,000USD3,888,000USD4,151,000USD3,886,000USD
    Other Non Cash Items1,157,000USD3,373,000USD18,278,000USD-23,697,000USD10,000USD876,000USD886,000USD657,000USD
    Change To Account Receivables-11,409,000USD8,900,000USD-8,900,000USD10,069,000USD-10,069,000USD362,000USD4,012,000USD16,218,000USD
    Change To Inventory-16,216,000USD-2,622,000USD2,622,000USD12,897,000USD-12,897,000USD-14,053,000USD-393,000USD-6,887,000USD
    Change In Working Capital-19,041,000USD9,321,000USD-9,321,000USD15,315,000USD-15,315,000USD7,935,000USD2,327,000USD-3,312,000USD
    Total Cash From Operating Activities40,061,000USD67,275,000USD65,572,000USD47,252,000USD36,457,000USD52,317,000USD51,302,000USD44,992,000USD
    Capital Expenditures-6,252,000USD-16,214,000USD-14,903,000USD-6,813,000USD-5,559,000USD-12,725,000USD-9,148,000USD-6,878,000USD
    Free Cash Flow33,809,000USD51,061,000USD50,669,000USD40,439,000USD30,898,000USD39,592,000USD42,154,000USD38,114,000USD
    Total Cashflows From Investing Activities-6,292,000USD-16,416,000USD-14,942,000USD-6,621,000USD-5,912,000USD-36,959,000USD-9,181,000USD-6,857,000USD
    Net Borrowings4,949,000USD9,951,000USD-36,048,000USD-48,000USD-49,000USD-37,047,000USD-39,627,000USD—
    Total Cash From Financing Activities-34,783,000USD-41,248,000USD-50,833,000USD-28,760,000USD-31,969,000USD-35,213,000USD-34,392,000USD-34,187,000USD
    Dividends Paid-30,769,000USD-11,000USD-11,000USD-2,000USD-28,263,000USD-4,000USD-4,000USD-13,000USD
    Sale Purchase Of Stock-15,690,000USD-53,628,000USD-15,419,000USD-33,264,000USD-5,325,000USD-306,000USD-163,000USD-11,000USD
    Change In Cash-1,697,000USD9,477,000USD-334,000USD15,526,000USD386,000USD-24,179,000USD9,956,000USD3,389,000USD
    Begin Period Cash Flow74,570,000USD65,093,000USD65,427,000USD49,901,000USD49,515,000USD73,694,000USD63,738,000USD60,349,000USD
    End Period Cash Flow72,873,000USD74,570,000USD65,093,000USD65,427,000USD49,901,000USD49,515,000USD73,694,000USD63,738,000USD
    Other Cashflows From Investing Activities2,000USD-43,835,000USD267,000USD-6,621,000USD-5,589,000USD169,000USD-80,000USD59,000USD
    Unclassified Financing Cash Flow6,727,000USD20,947,000USD—————-35,054,000USD
    Other Cashflows From Financing Activities—-18,507,000USD-48,000USD4,554,000USD1,668,000USD2,144,000USD5,402,000USD891,000USD
    Unclassified Investing Cash Flow—43,633,000USD14,636,000USD13,434,000USD11,148,000USD12,556,000USD9,228,000USD6,819,000USD
    Investments——-14,942,000USD-6,621,000USD-5,912,000USD-36,959,000USD-9,181,000USD-6,857,000USD
    Unclassified Operating Cash Flow—————-4,861,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income154,845,000USD128,475,000USD108,543,000USD105,367,000USD96,104,000USD84,623,000USD79,671,000USD78,573,000USD
    Depreciation45,690,000USD47,973,000USD54,935,000USD51,848,000USD48,879,000USD51,281,000USD45,862,000USD44,666,000USD
    Stock Based Compensation18,057,000USD16,675,000USD16,052,000USD13,224,000USD10,802,000USD8,303,000USD7,596,000USD6,413,000USD
    Other Non Cash Items-835,000USD1,772,000USD-4,965,000USD1,681,000USD-257,000USD2,381,000USD-146,000USD-1,541,000USD
    Change To Account Receivables-20,853,000USD5,582,000USD6,969,000USD-3,618,000USD-20,700,000USD-3,599,000USD11,623,000USD-7,773,000USD
    Change To Inventory3,635,000USD-22,791,000USD10,530,000USD-7,804,000USD-21,023,000USD13,923,000USD-11,401,000USD-6,016,000USD
    Change In Working Capital-7,463,000USD-6,117,000USD20,010,000USD-25,222,000USD10,930,000USD8,533,000USD-4,959,000USD-4,011,000USD
    Total Cash From Operating Activities216,556,000USD181,999,000USD183,761,000USD138,536,000USD160,514,000USD150,494,000USD124,461,000USD118,697,000USD
    Capital Expenditures-43,489,000USD-35,661,000USD-37,892,000USD-50,290,000USD-37,449,000USD-33,828,000USD-28,413,000USD-19,723,000USD
    Free Cash Flow173,067,000USD146,338,000USD145,869,000USD88,246,000USD123,065,000USD116,666,000USD96,048,000USD98,974,000USD
    Investments0USD-59,736,000USD-37,437,000USD-150,000USD-35,300,000USD-850,000USD-1,000,000USD-31,991,000USD
    Total Cashflows From Investing Activities-43,891,000USD-59,736,000USD-34,813,000USD-416,014,000USD-35,300,000USD-34,591,000USD-156,225,000USD-31,991,000USD
    Net Borrowings-26,194,000USD-119,785,000USD-131,222,000USD299,780,000USD-55,159,000USD-85,000,000USD75,002,000USD-64,893,000USD
    Total Cash From Financing Activities-152,810,000USD-133,815,000USD-153,321,000USD246,679,000USD-102,178,000USD-101,164,000USD43,385,000USD-71,447,000USD
    Dividends Paid-28,287,000USD-25,576,000USD-22,872,000USD-20,713,000USD-18,723,000USD-16,705,000USD-15,135,000USD-13,432,000USD
    Sale Purchase Of Stock-107,636,000USD-5,682,000USD-4,469,000USD-35,423,000USD-35,239,000USD-13,463,000USD-21,321,000USD-1,394,000USD
    Change In Cash25,055,000USD-14,932,000USD-2,113,000USD-36,679,000USD18,668,000USD18,899,000USD11,404,000USD13,852,000USD
    Begin Period Cash Flow49,515,000USD64,447,000USD66,560,000USD103,239,000USD84,571,000USD65,672,000USD54,268,000USD40,416,000USD
    End Period Cash Flow74,570,000USD49,515,000USD64,447,000USD66,560,000USD103,239,000USD84,571,000USD65,672,000USD54,268,000USD
    Other Cashflows From Investing Activities-43,568,000USD89,000USD1,881,000USD-415,864,000USD2,149,000USD-33,741,000USD-155,225,000USD5,131,000USD
    Other Cashflows From Financing Activities-16,887,000USD17,228,000USD5,242,000USD436,980,000USD11,943,000USD24,155,000USD173,408,000USD6,898,000USD
    Unclassified Operating Cash Flow6,262,000USD-6,779,000USD-10,814,000USD-8,362,000USD-5,944,000USD-4,627,000USD-3,563,000USD-5,403,000USD
    Unclassified Investing Cash Flow43,166,000USD35,572,000USD38,635,000USD50,290,000USD35,300,000USD33,828,000USD28,413,000USD14,592,000USD
    Unclassified Financing Cash Flow26,194,000USD——-433,945,000USD-5,000,000USD-10,151,000USD-168,569,000USD1,374,000USD
    Change To Liabilities———-15,247,000USD51,854,000USD867,000USD-4,530,000USD7,109,000USD
    Cash And Cash Equivalents Changes———-30,799,000USD23,036,000USD14,739,000USD11,621,000USD13,852,000USD
    Exchange Rate Changes———————-1,407,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational78,804,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States205,193,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductProduct Sales283,363,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductRoyalty634,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentAnimal Nutrition And Health64,454,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentHuman Nutrition And Health176,894,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentOther2,138,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentSpecialty Products40,511,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational73,327,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31GeographyUnited States197,382,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31ProductProduct Sales270,216,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31ProductRoyalty493,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31SegmentAnimal Nutrition And Health62,189,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31SegmentHuman Nutrition And Health171,628,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31SegmentOther2,165,000USD0000009326-26-000018
    Q1 2026Quarterly · 2026-03-31SegmentSpecialty Products34,727,000USD0000009326-26-000018
    Q4 2025Quarterly · 2025-12-31GeographyInternational74,661,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States188,956,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductProduct Sales263,092,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductRoyalty525,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentAnimal Nutrition And Health61,171,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentHuman Nutrition And Health166,069,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentOther1,544,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSpecialty Products34,833,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational277,713,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31GeographyUnited States759,448,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31ProductProduct Sales1,035,272,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31ProductRoyalty1,889,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31SegmentAnimal Nutrition And Health230,852,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31SegmentHuman Nutrition And Health659,387,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31SegmentOther5,946,000USD0000009326-26-000007
    FY 2025Yearly · 2025-12-31SegmentSpecialty Products140,976,000USD0000009326-26-000007
    Q3 2025Quarterly · 2025-09-30GeographyInternational69,494,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30GeographyUnited States198,064,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30ProductProduct Sales267,078,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30ProductRoyalty480,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30SegmentAnimal Nutrition And Health56,376,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30SegmentHuman Nutrition And Health174,088,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30SegmentOther1,411,000USD0000009326-25-000022
    Q3 2025Quarterly · 2025-09-30SegmentSpecialty Products35,683,000USD0000009326-25-000022
    Q2 2025Quarterly · 2025-06-30GeographyInternational68,761,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30GeographyUnited States186,706,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30ProductProduct Sales255,041,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30ProductRoyalty426,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30SegmentAnimal Nutrition And Health56,028,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30SegmentHuman Nutrition And Health160,773,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30SegmentOther1,481,000USD0000009326-25-000014
    Q2 2025Quarterly · 2025-06-30SegmentSpecialty Products37,185,000USD0000009326-25-000014
    Q1 2025Quarterly · 2025-03-31GeographyInternational64,797,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31GeographyUnited States185,722,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31ProductProduct Sales250,061,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31ProductRoyalty458,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31SegmentAnimal Nutrition And Health57,277,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31SegmentHuman Nutrition And Health158,457,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31SegmentOther1,510,000USD0000009326-26-000018
    Q1 2025Quarterly · 2025-03-31SegmentSpecialty Products33,275,000USD0000009326-26-000018
    Q4 2024Quarterly · 2024-12-31GeographyInternational58,472,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States181,532,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductProduct Sales239,573,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductRoyalty431,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentAnimal Nutrition And Health58,326,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentHuman Nutrition And Health147,303,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentOther1,524,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSpecialty Products32,851,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational230,384,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31GeographyUnited States723,300,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31ProductProduct Sales951,947,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31ProductRoyalty1,737,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31SegmentAnimal Nutrition And Health214,710,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31SegmentHuman Nutrition And Health600,258,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31SegmentOther5,967,000USD0000009326-26-000007
    FY 2024Yearly · 2024-12-31SegmentSpecialty Products132,749,000USD0000009326-26-000007
    Q3 2024Quarterly · 2024-09-30GeographyInternational57,950,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30GeographyUnited States181,990,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30ProductProduct Sales239,522,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30ProductRoyalty418,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30SegmentAnimal Nutrition And Health52,906,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30SegmentHuman Nutrition And Health152,283,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30SegmentOther1,560,000USD0000009326-25-000022
    Q3 2024Quarterly · 2024-09-30SegmentSpecialty Products33,191,000USD0000009326-25-000022
    FY 2023Yearly · 2023-12-31GeographyInternational232,838,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31GeographyUnited States689,601,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31ProductProduct Sales919,951,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31ProductRoyalty2,488,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31SegmentAnimal Nutrition And Health238,326,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31SegmentHuman Nutrition And Health550,751,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31SegmentOther7,397,000USD0000009326-26-000007
    FY 2023Yearly · 2023-12-31SegmentSpecialty Products125,965,000USD0000009326-26-000007
    FY 2022Yearly · 2022-12-31GeographyInternational260,120,000USD0001628280-25-007202
    FY 2022Yearly · 2022-12-31GeographyUnited States682,238,000USD0001628280-25-007202
    FY 2022Yearly · 2022-12-31ProductBill And Hold0USD0001628280-23-005074
    FY 2022Yearly · 2022-12-31ProductCo Manufacturing40,621,000USD0001628280-23-005074
    FY 2022Yearly · 2022-12-31ProductConsignment4,227,000USD0001628280-23-005074
    FY 2022Yearly · 2022-12-31ProductProduct Sales894,318,000USD0001628280-23-005074
    FY 2022Yearly · 2022-12-31ProductRoyalty3,192,000USD0001628280-23-005074
    FY 2022Yearly · 2022-12-31SegmentAnimal Nutrition And Health262,297,000USD0001628280-25-007202
    FY 2022Yearly · 2022-12-31SegmentHuman Nutrition And Health527,131,000USD0001628280-25-007202
    FY 2022Yearly · 2022-12-31SegmentOther21,492,000USD0001628280-25-007202
    FY 2022Yearly · 2022-12-31SegmentSpecialty Products131,438,000USD0001628280-25-007202
    FY 2021Yearly · 2021-12-31GeographyInternational214,362,000USD0001628280-24-005397

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.